|
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): March 22, 2004
|
CROMPTON CORPORATION |
|
(Exact name of registrant as specified in its charter) |
|
|
|
|
|
Delaware |
0-30270 |
52-2183153 |
|
(State or other jurisdiction of |
(Commission File Number) |
(I.R.S. Employer |
|
|
|
|
|
|
|
|
|
(Address of principal executive offices) |
(Zip Code) |
|
|
|
|
|
|
(203) 573-
2000 |
||
Item 5. Other Events and Regulation FD Disclosure.
Crompton Corporation announced today that it has entered into definitive agreements to sell its 50 percent share of its Gustafson seed treatment business in the United States, Canada and Mexico [NAFTA] to Bayer CropScience LP in the U.S. and Bayer CropScience Inc. in Canada, for the purchase price of $124 million in cash. In 2003, Gustafson sales were approximately $130 million. Crompton will continue to participate in the global seed treatment business. In the NAFTA region, Crompton will supply seed treatment products through the Bayer CropScience-Gustafson business. Crompton's seed treatment business outside of NAFTA will be unaffected by the transaction. A copy of a press release describing the transaction is attached as exhibit 99.1 hereto and is herein incorporated by reference.
Item 7. Financial Statements and Exhibits.
* * *
(c) Exhibits.
|
Exhibit Number |
Exhibit Description |
|
99.1 |
Press Release Dated March 22, 2004 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned duly authorized.
|
Crompton Corporation |
|
|
By: /s/ Barry J. Shainman |
Date: March 22, 2004
|
Exhibit Index |
|
|
Exhibit Number |
Exhibit Description |
|
99.1 |
Press Release Dated March 22, 2004 |